Federal contract award
HHSN272201400004C
IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541711 |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $38.4M |
| Current contract value | $38.4M |
| Potential contract value / ceiling | $105.1M |
| Start date | Jan 9, 2014 |
| Current end date | Jul 31, 2022 |
| Potential end date | Jul 31, 2022 |
| Latest award activity | Aug 27, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 32 of 32 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 27, 2026 | P00031 | $-201 | TO ADMINISTRATE DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS. |
| Sep 23, 2025 | P00030 | $-42.1K | EO14042: NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Sep 3, 2025 | P00029 | $-0 | EO14042: NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Sep 23, 2024 | P00028 | $-126.9K | EO14042: NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Jul 31, 2022 | P00027 | $-123.7K | EO14042: NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Jun 21, 2022 | P00026 | $-2.3K | EO14042: NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Jun 8, 2022 | P00025 | $0 | EO14042: NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Nov 14, 2021 | P00024 | $0 | EO14042: NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Apr 23, 2021 | P00023 | $550.5K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Mar 26, 2021 | P00022 | $238.4K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Aug 1, 2020 | P00021 | $267.7K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Jun 18, 2020 | P00020 | $311.2K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Jun 2, 2020 | P00019 | $2.2M | COVID-19; NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Apr 28, 2020 | P00018 | $1.0M | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Mar 18, 2020 | P00017 | $4.0M | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Aug 1, 2019 | P00016 | $504.4K | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION 5, REVISE NON-SEVERABLE POPS, AND UPDATE CLAUSES. |
| Jun 11, 2019 | P00015 | $-41.5K | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION 5, REVISE NON-SEVERABLE POPS, AND UPDATE CLAUSES. |
| Apr 15, 2019 | P00014 | $4.1M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION 5, REVISE NON-SEVERABLE POPS, AND UPDATE CLAUSES. |
| Mar 29, 2019 | P00013 | $0 | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION 5, REVISE NON-SEVERABLE POPS, AND UPDATE CLAUSES. |
| Sep 14, 2018 | 12 | $2.7M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTIONS, REVISE NON-SEVERABLE OPTION END DATES, MAKE EQUITABLE ADJUSTMENTS, AND UPDATE VARIOUS CLAUSES AND ARTICLES. |
| Mar 21, 2018 | 11 | $4.2M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION 4, OPTION 18G, REMOVE THE FISMA REQUIREMENTS OF ARTICLE H.22, EXTEND THE PERIOD OF PERFORMANCE FOR OPTIONS 17B&18D, AND UPDATE NEW CONTRACTING OFFICERS REPRESENTATIVE (COR). |
| Aug 17, 2017 | 10 | $1.4M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Mar 14, 2017 | 9 | $3.8M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Sep 23, 2016 | 8 | $152.6K | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Sep 12, 2016 | 7 | $1.1M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| May 26, 2016 | 6 | $0 | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Mar 16, 2016 | 5 | $3.7M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Feb 9, 2016 | 4 | $0 | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Aug 13, 2015 | 3 | $328.2K | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Mar 18, 2015 | 2 | $3.6M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Sep 12, 2014 | 1 | $919.0K | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
| Jan 9, 2014 | 0 | $3.6M | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.